BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 6589046)

  • 1. Cell cycle events associated with the termination of proliferation by cytotoxic and differentiation-inducing actions of 6-thioguanine on HL-60 cells.
    Schwartz EL; Blair OC; Sartorelli AC
    Cancer Res; 1984 Sep; 44(9):3907-10. PubMed ID: 6589046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytotoxic and cytodifferentiative components of 6-thioguanine resistance in HL-60 cells containing acquired double minute chromosomes.
    Gallagher RE; Ferrari AC; Zulich AW; Yen RW; Testa JR
    Cancer Res; 1984 Jun; 44(6):2642-53. PubMed ID: 6586289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for cell cycle phase-specific initiation of a program of HL-60 cell myeloid differentiation mediated by inducer uptake.
    Yen A; Albright KL
    Cancer Res; 1984 Jun; 44(6):2511-5. PubMed ID: 6327017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced mitogenic responsiveness to granulocyte-macrophage colony-stimulating factor in HL-60 promyelocytic leukemia cells upon induction of differentiation.
    Schwartz EL; Maher AM
    Cancer Res; 1988 May; 48(10):2683-7. PubMed ID: 2834046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imbalance in the nucleotide pools of myeloid leukemia cells and HL-60 cells: correlation with cell-cycle phase, proliferation, differentiation, and transformation.
    de Korte D; Haverkort WA; de Boer M; van Gennip AH; Roos D
    Cancer Res; 1987 Apr; 47(7):1841-7. PubMed ID: 3469022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Terminal differentiation of the human promyelocytic leukemia cell line, HL-60, in the absence of cell proliferation.
    Ferrero D; Tarella C; Gallo E; Ruscetti FW; Breitman TR
    Cancer Res; 1982 Nov; 42(11):4421-6. PubMed ID: 6957259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of 6-thioguanine activity by guanine in human promyelocytic leukemia HL-60 cells.
    Cheng HW; Armstrong RD; Sadée W
    Cancer Res; 1988 Jul; 48(13):3648-51. PubMed ID: 3163939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of the metabolic forms of 6-thioguanine responsible for cytotoxicity and induction of differentiation of HL-60 acute promyelocytic leukemia cells.
    Ishiguro K; Schwartz EL; Sartorelli AC
    J Cell Physiol; 1984 Nov; 121(2):383-90. PubMed ID: 6593322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thioguanine-induced S and G2 blocks and their significance to the mechanism of cytotoxicity.
    Wotring LL; Roti Roti JL
    Cancer Res; 1980 May; 40(5):1458-62. PubMed ID: 7370984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of proliferation-associated nuclear autoantigens, p330d/CENP-F and PCNA, in differentiation and in drug-induced growth inhibition using two-parameter flow cytometry.
    Báez A; Torres K; Tan EM; Pommier Y; Casiano CA
    Cell Prolif; 1996 Apr; 29(4):183-96. PubMed ID: 8695747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of HL-60 leukemia cell differentiation by the novel antifolate 5,10-dideazatetrahydrofolic acid.
    Sokoloski JA; Beardsley GP; Sartorelli AC
    Cancer Res; 1989 Sep; 49(17):4824-8. PubMed ID: 2758415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell differentiation and cell cycle effects on human promyelocytic leukemia cells induced by 12-O-tetradecanoylphorbol-13-acetate.
    Yun K; Sugihara H
    Lab Invest; 1986 Mar; 54(3):336-44. PubMed ID: 3456469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancement of the differentiation-inducing properties of 6-thioguanine by hypoxanthine and its nucleosides in HL-60 promyelocytic leukemia cells.
    Ishiguro K; Sartorelli AC
    Cancer Res; 1985 Jan; 45(1):91-5. PubMed ID: 3855287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversible effects of retinoic acid on glycosaminoglycan synthesis during differentiation of HL-60 leukemia cells.
    Reiss M; Maniglia CA; Sartorelli AC
    Cancer Res; 1985 May; 45(5):2092-7. PubMed ID: 3857115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alterations in tyrosine phosphorylation during the granulocytic maturation of HL-60 leukemia cells.
    Frank DA; Sartorelli AC
    Cancer Res; 1988 Jan; 48(1):52-8. PubMed ID: 2825968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergistic effects of curcumin on all-trans retinoic acid- and 1 alpha,25-dihydroxyvitamin D3-induced differentiation in human promyelocytic leukemia HL-60 cells.
    Liu Y; Chang RL; Cui XX; Newmark HL; Conney AH
    Oncol Res; 1997; 9(1):19-29. PubMed ID: 9112257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential effects of retinoic acid (RA) and N-(4-hydroxyphenyl) retinamide (4-HPR) on cell growth, induction of differentiation, and changes in p34cdc2, Bcl-2, and actin expression in the human promyelocytic HL-60 leukemic cells.
    Dipietrantonio A; Hsieh TC; Wu JM
    Biochem Biophys Res Commun; 1996 Jul; 224(3):837-42. PubMed ID: 8713132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell cycle-related expression of p120 nucleolar antigen in normal human lymphocytes and in cells of HL-60 and MOLT-4 leukemic lines: effects of methotrexate, camptothecin, and teniposide.
    Gorczyca W; Bruno S; Melamed MR; Darzynkiewicz Z
    Cancer Res; 1992 Jun; 52(12):3491-4. PubMed ID: 1596908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. c-myc down regulation and precommitment in HL-60 cells due to bromodeoxyuridine.
    Yen A; Forbes ME
    Cancer Res; 1990 Mar; 50(5):1411-20. PubMed ID: 2302706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence of multifactorial mechanisms in an adriamycin-resistant HL-60 promyelocytic leukemia cell line.
    Burres NS; Myers MT; Sartorelli AC
    Cancer Biochem Biophys; 1988 Jul; 10(1):47-57. PubMed ID: 3224331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.